BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24008362)

  • 21. Maternal cholestasis does not affect the ontogenic pattern of expression of the Na+/taurocholate cotransporting polypeptide (ntcp) in the fetal and neonatal rat liver.
    Arrese M; Trauner M; Ananthanarayanan M; Boyer JL; Suchy FJ
    Hepatology; 1998 Sep; 28(3):789-95. PubMed ID: 9731574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
    Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
    Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular uptake of hepatitis B virus envelope L particles is independent of sodium taurocholate cotransporting polypeptide, but dependent on heparan sulfate proteoglycan.
    Somiya M; Liu Q; Yoshimoto N; Iijima M; Tatematsu K; Nakai T; Okajima T; Kuroki K; Ueda K; Kuroda S
    Virology; 2016 Oct; 497():23-32. PubMed ID: 27420796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters.
    Anwer MS; Stieger B
    Pflugers Arch; 2014 Jan; 466(1):77-89. PubMed ID: 24196564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysosomal targeting of the CLN7 membrane glycoprotein and transport via the plasma membrane require a dileucine motif.
    Steenhuis P; Herder S; Gelis S; Braulke T; Storch S
    Traffic; 2010 Jul; 11(7):987-1000. PubMed ID: 20406422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry.
    Fu L; Hu H; Liu Y; Jing Z; Li W
    Virology; 2017 May; 505():1-11. PubMed ID: 28213271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity.
    Leslie EM; Watkins PB; Kim RB; Brouwer KL
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1170-8. PubMed ID: 17374746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump.
    Mita S; Suzuki H; Akita H; Stieger B; Meier PJ; Hofmann AF; Sugiyama Y
    Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G159-67. PubMed ID: 15297262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
    Liu C; Xu G; Gao Z; Zhou Z; Guo G; Li D; Jing Z; Sui J; Li W
    Virology; 2018 Sep; 522():168-176. PubMed ID: 30032030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.
    Kim RB; Leake B; Cvetkovic M; Roden MM; Nadeau J; Walubo A; Wilkinson GR
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1204-9. PubMed ID: 10565843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term regulation of bile acid uptake by microfilament-dependent translocation of rat ntcp to the plasma membrane.
    Dranoff JA; McClure M; Burgstahler AD; Denson LA; Crawford AR; Crawford JM; Karpen SJ; Nathanson MH
    Hepatology; 1999 Jul; 30(1):223-9. PubMed ID: 10385660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression.
    Tsukuda S; Watashi K; Iwamoto M; Suzuki R; Aizaki H; Okada M; Sugiyama M; Kojima S; Tanaka Y; Mizokami M; Li J; Tong S; Wakita T
    J Biol Chem; 2015 Feb; 290(9):5673-84. PubMed ID: 25550158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP.
    Appelman MD; Wettengel JM; Protzer U; Oude Elferink RPJ; van de Graaf SFJ
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Aug; 1866(8):158960. PubMed ID: 33932583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
    Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
    J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.
    He W; Cao Z; Mao F; Ren B; Li Y; Li D; Li H; Peng B; Yan H; Qi Y; Sun Y; Wang F; Sui J; Li W
    J Virol; 2016 Oct; 90(19):8866-74. PubMed ID: 27466423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PKC{epsilon}-dependent and -independent effects of taurolithocholate on PI3K/PKB pathway and taurocholate uptake in HuH-NTCP cell line.
    Schonhoff CM; Yamazaki A; Hohenester S; Webster CR; Bouscarel B; Anwer MS
    Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1259-67. PubMed ID: 19815625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tauroursodeoxycholate Protects Rat Hepatocytes from Bile Acid-Induced Apoptosis via β1-Integrin- and Protein Kinase A-Dependent Mechanisms.
    Sommerfeld A; Reinehr R; Häussinger D
    Cell Physiol Biochem; 2015; 36(3):866-83. PubMed ID: 26044599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis.
    Gartung C; Matern S
    Yale J Biol Med; 1997; 70(4):355-63. PubMed ID: 9626756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype.
    Vaz FM; Paulusma CC; Huidekoper H; de Ru M; Lim C; Koster J; Ho-Mok K; Bootsma AH; Groen AK; Schaap FG; Oude Elferink RP; Waterham HR; Wanders RJ
    Hepatology; 2015 Jan; 61(1):260-7. PubMed ID: 24867799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico identification of potential cholestasis-inducing agents via modeling of Na(+)-dependent taurocholate cotransporting polypeptide substrate specificity.
    Greupink R; Nabuurs SB; Zarzycka B; Verweij V; Monshouwer M; Huisman MT; Russel FG
    Toxicol Sci; 2012 Sep; 129(1):35-48. PubMed ID: 22641618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.